BREAKING
CVS Health (CVS) Q4 2025 revenue rises 8%; adjusted earnings decline 58 minutes ago Chegg Q4 2025 Earnings Soar: New Strategy Stuns Market 13 hours ago PAL Q4 2025 Earnings Explode: Mergers Pay Off Now 13 hours ago Outdoor Holding Company Q3 2026 Earnings Soar 7% 16 hours ago Apollo Q4 2025 Earnings Rocket: Historic AUM Breakthrough 18 hours ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 20 hours ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 22 hours ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 24 hours ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 1 day ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 1 day ago CVS Health (CVS) Q4 2025 revenue rises 8%; adjusted earnings decline 58 minutes ago Chegg Q4 2025 Earnings Soar: New Strategy Stuns Market 13 hours ago PAL Q4 2025 Earnings Explode: Mergers Pay Off Now 13 hours ago Outdoor Holding Company Q3 2026 Earnings Soar 7% 16 hours ago Apollo Q4 2025 Earnings Rocket: Historic AUM Breakthrough 18 hours ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 20 hours ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 22 hours ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 24 hours ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 1 day ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 1 day ago
ADVERTISEMENT

HEXO Earnings: Highlights of Hexo’s Q2 2022 financial results

Cannabis producer HEXO Corp. (NASDAQ: HEXO) has reported a wider net loss for the second quarter of 2022. However, the Canada-based company’s revenues increased 61% during the three-month period. Net loss and comprehensive loss widened to C$690.3 million in the January quarter from C$20.8 million in the prior-year period. At C$52.8 million, net revenues were […]

March 22, 2022 1 min read

Cannabis producer HEXO Corp. (NASDAQ: HEXO) has reported a wider net loss for the second quarter of 2022. However, the Canada-based company’s revenues increased 61% during the three-month period.

HEXO Q2 2022 earnings infographic

Net loss and comprehensive loss widened to C$690.3 million in the January quarter from C$20.8 million in the prior-year period.

At C$52.8 million, net revenues were up 61% year-over-year, reflecting double-digit growth in the adult-use and medical cannabis segments. International cannabis revenues more than doubled.


Read management/analysts’ comments on quarterly reports

ADVERTISEMENT

The value of Hexo shares more than halved in the past six months at the Nasdaq stock exchange and slipped below one dollar. The stock traded lower in early trading on Tuesday.

Prior Performance

  • Hexo Q4 2021 earnings results

ADVERTISEMENT